Neda Kalhor, M.D.

Peer-Reviewed Articles

1. Mosaffa SL, Eapen G, Kalhor N, Sneige N. Non-small cell lung carcinoma with ectopic gonadotropin production: A case report and review of the literature. Diagn Cytopathol. e-Pub 2024. PMID: 38576061.
2. Salem A, Wu Y, Albarracin CT, Middleton LP, Kalhor N, Peng Y, Huang X, Aung PP, Chen H, Sahin AA, Ding Q. A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland. Hum Pathol 145:42-47. e-Pub 2024. PMID: 38262580.
3. Diao S, Chen P, Showkatian E, Bandyopadhyay R, Rojas FR, Zhu B, Hong L, Aminu M, Saad MB, Salehjahromi M, Muneer A, Sujit SJ, Behrens C, Gibbons DL, Heymach JV, Kalhor N, Wistuba II, Solis Soto LM, Zhang J, Qin W, Wu J. Automated Cellular-Level Dual Global Fusion of Whole-Slide Imaging for Lung Adenocarcinoma Prognosis. Cancers (Basel) 15(19), 2023. e-Pub 2023. PMID: 37835518.
4. Chen P, Rojas FR, Hu X, Serrano A, Zhu B, Chen H, Hong L, Bandyoyadhyay R, Aminu M, Kalhor N, Lee JJ, El Hussein S, Khoury JD, Pass HI, Moreira AL, Velcheti V, Sterman DH, Fukuoka J, Tabata K, Su D, Ying L, Gibbons DL, Heymach JV, Wistuba II, Fujimoto J, Solis Soto LM, Zhang J, Wu J. Pathomic Features Reveal Immune and Molecular Evolution from Lung Preneoplasia to Invasive Adenocarcinoma. Mod Pathol:100326. e-Pub 2023. PMID: 37678674.
5. Lizarraga Madrigal D, Cabrera Charleston M, Khan A, Eapen G, Kalhor N, Gan Q, Grosu H. Pulmonary Sclerosing Pneumocytomas Mimicking Lung Cancer. Cureus 15(4):e37395, 2023. e-Pub 2023. PMID: 37182004.
6. Francisco-Cruz A, Rocha P, Reuben A, Krishnan SN, Das P, Chen R, Quek K, Li J, Parra ER, Solis LM, Barua S, Jiang M, Lazcano R, Chow CW, Behrens C, Gumb C, Little L, Fukuoka J, Kalhor N, Weissferdt A, Kadara H, Heymach JV, Swisher S, Sepesi B, Rao A, Moran C, Zhang J, Lee JJ, Fujimoto J, Futreal PA, Wistuba II, Peterson CB, Zhang J. Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer. Mod Pathol 36(1):100028, 2023. PMID: 36788067.
7. Liu Y, Yao L, Kalhor N, Carter BW, Altan M, Blumenschein G, Byers LA, Fossella F, Gibbons DL, Kurie JM, Lu C, Skoulidis F, Chang JY, Liao Z, Gomez DR, O'Reilly M, Heymach JV, Tsao AS, Lin SH. Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial. Lung Cancer 174:112-117, 2022. e-Pub 2022. PMID: 36371941.
8. Akhave N, Zhang J, Bayley E, Frank M, Chiou SH, Behrens C, Chen R, Hu X, Parra ER, Lee WC, Swisher S, Solis L, Weissferdt A, Moran C, Kalhor N, Zhang J, Scheet P, Vaporciyan AA, Sepesi B, Gibbons DL, Heymach JV, Lee JJ, Wistuba II, Andrew Futreal P, Zhang J, Fujimoto J, Reuben A. Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment. Lung Cancer 172:19-28, 2022. e-Pub 2022. PMID: 35973335.
9. Tang M, Abbas HA, Negrao MV, Ramineni M, Hu X, Hubert SM, Fujimoto J, Reuben A, Varghese S, Zhang J, Li J, Chow CW, Mao X, Song X, Lee WC, Wu J, Little L, Gumbs C, Behrens C, Moran C, Weissferdt A, Lee JJ, Sepesi B, Swisher S, Cheng C, Kurie J, Gibbons D, Heymach JV, Wistuba II, Futreal PA, Kalhor N, Zhang J. The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics. Nat Commun 12(1):7081, 2021. e-Pub 2021. PMID: 34873156.
10. Rocha P, Salazar R, Zhang J, Ledesma D, Solorzano JL, Mino B, Villalobos P, Dejima H, Douse DY, Diao L, Mitchell KG, Le X, Zhang J, Weissferdt A, Parra-Cuentas E, Cascone T, Rice DC, Sepesi B, Kalhor N, Moran C, Vaporciyan A, Heymach J, Gibbons DL, Lee JJ, Kadara H, Wistuba I, Behrens C, Solis LM. Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma. Cancer Immunol Immunother 70(7):1977-1978, 2021. e-Pub 2021. PMID: 33686493.
11. Kadara H, Choi M, Zhang J, Parra ER, Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Yoo Y, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons DL, Heymach J, Kaftan E, Townsend JP, Lynch TJ, Schlessinger J, Lee J, Lifton RP, Wistuba II, Herbst RS. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up. Ann Oncol 29(4):1072, 2018. PMID: 29688333.
12. Weissferdt A, Kalhor N, Moran CA. Cystic well differentiated squamous cell carcinoma of the thymus A clinicopathological and immunohistochemical study of 6 cases. Histopathology 68(3):333-8, 2016. e-Pub 2015. PMID: 26031186.
13. Falk N, Weissferdt A, Kalhor N, Moran C. Primary Pulmonary Salivary Gland-type Tumors: A Review and Update. Adv Anat Pathol 23(1):13-23, 2016.
14. Zhang YA, Ma X, Sathe A, Fujimoto J, Wistuba II, Lam S, Yatabe Y, Wang YW, Stastny V, Gao B, Larsen JE, Girard L, Liu X, Song K, Behrens C, Kalhor N, Xie Y, Zhang MQ, Minna JD, Gazdar AF. Validation of SCT Methylation As a Hallmark Biomarker for Lung Cancers. J Thorac Oncol. e-Pub 2015. PMID: 26725182.
15. Weissferdt A,Kalhor N, Moran C. Primary thymic cholesteroloma: a clinicopathological correlation of four cases of an unusual benign lesion. Virchows Arch 467(5):609-11, 2015. e-Pub 2015. PMID: 26266777.
16. Piña-Oviedo S, Weissferdt A, Kalhor N, Moran CA. Primary Pulmonary Lymphomas. Adv Anat Pathol 22(6):355-75, 2015. PMID: 26452211.
17. Liu W, Hu S, Konopleva M, Khoury JD, Kalhor N, Tang G, Bueso-Ramos CE, Jorgensen JL, Lin P, Medeiros LJ, Lu X. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis. Pediatr Hematol Oncol:1-13. e-Pub 2015. PMID: 26558423.
18. Song S, Honjo S, Jin J, Chang SS, Scott AW, Chen Q,Kalhor N, Correa AM, Hofstetter WL, Albarracin CT, Wu TT, Johnson RL, Hung MC, Ajani JA. The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer. Clin Cancer Res 21(11):2580-90, 2015. e-Pub 2015. PMID: 25739674.
19. Zenali MJ, Weissferdt A, Solis LM, Ali S, Tang X, Mehran RJ, Wistuba II, Moran CA, Kalhor N. An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung. Hum Pathol 46(6):836-42, 2015. e-Pub 2015. PMID: 25776025.
20. Weissferdt A,Kalhor N, Moran CA. Ewing sarcoma with extensive neural differentiation: a clinicopathologic, immunohistochemical, and molecular analysis of three cases. Am J Clin Pathol 143(5):659-64, 2015. PMID: 25873499.
21. Guo C, Hao C, Shao R, Fang B, Correa AM, Hofstetter WL, Roth JA, Behrens C, Kalhor N, Wistuba II, Swisher SG, Pataer A. RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer. Oncotarget 6(13):11114-24, 2015. PMID: 25798539.
22. Zhang J, Fujimoto J, Zhang J, Wedge DC, Song X, Zhang J, Seth S, Chow CW, Cao Y, Gumbs C, Gold KA, Kalhor N, Little L, Mahadeshwar H, Moran C, Protopopov A, Sun H, Tang J, Wu X, Ye Y, William WN, Lee JJ, Heymach JV, Hong WK, Swisher S, Wistuba II, Futreal PA. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346(6206):256-9, 2014. PMID: 25301631.
23. Weissferdt A, Kalhor N, Liu H, Rodriguez J, Fujimoto J, Tang X, Wistuba II, Moran CA. Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases. Hum Pathol. e-Pub 2014. PMID: 25294372.
24. Kim ES, Tang X, Peterson DR, Kilari D, Chow CW, Fujimoto J, Kalhor N, Swisher SG, Stewart DJ, Wistuba II, Siddik ZH. Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer. Lung Cancer 85(1):88-93, 2014. e-Pub 2014. PMID: 24792335.
25. Kalhor N. Colloid carcinoma of the lung: Current views. Semin Diagn Pathol 31(4):265-70, 2014. e-Pub 2014. PMID: 25239272.
26. Weissferdt A, Kalhor N, Moran CA. Lung carcinoma: Beyond the WHO classification. Semin Diagn Pathol. e-Pub 2014. PMID: 25002355.
27. Weissferdt A, Kalhor N, Moran CA. Combined thymoma-thymic seminoma. Report of 2 cases of a heretofore unreported association. Hum Pathol. e-Pub 2014. PMID: 25090916.
28. Kadara H, Fujimoto J, Yoo SY, Maki Y, Gower AC, Kabbout M, Garcia MM, Chow CW, Chu Z, Mendoza G, Shen L, Kalhor N, Hong WK, Moran C, Wang J, Spira A, Coombes KR, Wistuba II. Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer. J Natl Cancer Inst 106(3):dju004, 2014. e-Pub 2014. PMID: 24563515.
29. Kanagal-Shamanna R, Portier BP, Singh RR, Routbort MJ, Aldape KD, Handal BA, Rahimi H, Reddy NG, Barkoh BA, Mishra BM, Paladugu AV, Manekia JH, Kalhor N, Chowdhuri SR, Staerkel GA, Medeiros LJ, Luthra R, Patel KP. Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics. Mod Pathol 27(2):314-27, 2014. e-Pub 2013. PMID: 23907151.
30. Hellmann MD, Chaft JE, William WN, Rusch V, Pisters KM, Kalhor N, Pataer A, Travis WD, Swisher SG, Kris MG, University of Texas MD Anderson Lung Cancer Collaborative Group. Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. Lancet Oncol 15(1):e42-50, 2014. PMID: 24384493.
31. Almeida MF, Patnana M, Korivi BR, Kalhor N, Marcal L. Ewing sarcoma of the kidney: a rare entity. Case Rep Radiol 2014:283902, 2014. e-Pub 2014. PMID: 24523977.
32. Behrens C, Solis Soto LM, Lin HY, Yuan P, Tang X, Kadara H, Riquelme E, Galindo H, Moran C, Kalhor N, Swisher SG, Simon G, Stewart DJ, Lee JJ, Wistuba II. EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma. Clin Cancer Res 19(23), 2013. e-Pub 2013. PMID: 24097870.
33. Wistuba II, Behrens C, Lombardi F, Wagner S, Fujimoto J, Raso MG, Spaggiari L, Galetta D, Riley R, Hughes E, Reid J, Sangale Z, Swisher SG, Kalhor N, Moran CA, Gutin A, Lanchbury JS, Barberis M, Kim ES. Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma. Clin Cancer Res 19(22). e-Pub 2013. PMID: 24048333.
34. Weissferdt A, Kalhor N, Moran CA. Well-differentiated adenocarcinoma-bronchioloalveolar carcinoma-in situ adenocarcinoma: a conundrum. Adv Anat Pathol 20(5):347-351, 2013. e-Pub 2013. PMID: 23939151.
35. Weissferdt A, Kalhor N, Marom EM, Benveniste MF, Godoy MC, Correa AM, Swisher SG, Moran CA. Early-stage pulmonary adenocarcinoma (T1N0M0): a clinical, radiological, surgical, and pathological correlation of 104 cases. The MD Anderson Cancer Center Experience. Mod Pathol 26(8):1065-1075, 2013. PMID: 23542459.
36. David E, Thall PF, Kalhor N, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Wei C, Mehran RJ. Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size. Ann Thorac Surg 95(6):1872-1877, 2013. e-Pub 2013. PMID: 23643547.
37. Kalhor N, Wistuba II. Perfecting the fine-needle aspirate cell block. Cancer Cytopathol 121(3):109-10, 2013. PMID: 23614136.
38. William WN, Pataer A, Kalhor N, Correa AM, Rice DC, Wistuba II, Heymach J, Lee JJ, Kim ES, Munden R, Gold KA, Papadimitrakopoulou V, Swisher SG, Erasmus JJ, University of Texas M.D. Anderson Lung Cancer Collaborative Research Group. Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non-Small-Cell Lung Cancer after Neoadjuvant Chemotherapy. J Thorac Oncol 8(2):222-8, 2013. e-Pub 2013. PMID: 23287849.
39. Fujimoto J, Kadara H, Garcia MM, Kabbout M, Behrens C, Liu DD, Lee JJ, Solis LM, Kim ES, Kalhor N, Moran C, Sharafkhaneh A, Lotan R, Wistuba II. g-Protein Coupled Receptor Family C, Group 5, Member A (gprc5a) Expression Is Decreased in the Adjacent Field and Normal Bronchial Epithelia of Patients with Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer. J Thorac Oncol 7(12):1747-54, 2012. PMID: 23154545.
40. Kalhor N, Moran CA. Thymoma: current concepts. Oncology (Williston Park) 26(10):975-81, 2012. PMID: 23176011.
41. Byers LA, Wang J, Nilsson MB, Fujimoto J, Saintigny P, Yordy J, Giri U, Peyton M, Fan YH, Diao L, Masrorpour F, Shen L, Liu W, Duchemann B, Tumula P, Bhardwaj V, Welsh J, Weber S, Glisson BS, Kalhor N, Wistuba II, Girard L, Lippman SM, Mills GB, Coombes KR, Weinstein JN, Minna JD, Heymach JV. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discov 2(9):798-811, 2012. e-Pub 2012. PMID: 22961666.
42. Kim ES, Lee JJ, He G, Chow CW, Fujimoto J, Kalhor N, Swisher SG, Wistuba II, Stewart DJ, Siddik ZH. Tissue Platinum Concentration and Tumor Response in Non-Small-Cell Lung Cancer. J Clin Oncol. e-Pub 2012. PMID: 22891266.
43. Solis LM, Behrens C, Raso MG, Lin HY, Kadara H, Yuan P, Galindo H, Tang X, Lee JJ, Kalhor N, Wistuba II, Moran CA. Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer 118(11):2889-99, 2012. e-Pub 2011. PMID: 22020674.
44. Pataer A, Kalhor N, Correa AM, Raso MG, Erasmus JJ, Kim ES, Behrens C, Lee JJ, Roth JA, Stewart DJ, Vaporciyan AA, Wistuba II, Swisher SG. Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy. J Thorac Oncol 7(5):825-832, 2012. PMID: 22481232.
45. Nunez MI, Behrens C, Woods DM, Lin H, Suraokar M, Kadara H, Hofstetter W, Kalhor N, Lee JJ, Franklin W, Stewart DJ, Wistuba II. High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and Mutation. J Thorac Oncol 7(5):833-840, 2012. PMID: 22729036.
46. Moran CA, Weissferdt A, Kalhor N, Solis LM, Behrens C, Wistuba II, Suster S. Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the world health organization schema. Am J Clin Pathol 137(3):444-50, 2012. PMID: 22338057.
47. Kalhor N, Suster S, Moran CA. Primary Pulmonary Chondrosarcomas: A clinicopathologic study of 4 cases. Hum Pathol 42(11):1629-34, 2011. e-Pub 2011. PMID: 21496864.
48. Tsuta K, Kalhor N, Wistuba II, Moran CA. Clinicopathological and immunohistochemical analysis of spindle-cell carcinoid tumour of the lung. Histopathology 59(3):526-36, 2011. PMID: 22034892.
49. Tsuta K, Liu DC, Kalhor N, Wistuba II, Moran CA. Using the mitosis-specific marker anti-phosphohistone h3 to assess mitosis in pulmonary neuroendocrine carcinomas. Am J Clin Pathol 136(2):252-9, 2011. PMID: 21757598.
50. Weissferdt A, Hernandez JC,Kalhor N, Moran CA. Spindle Cell Thymomas: An Immunohistochemical Study of 30 Cases. Appl Immunohistochem Mol Morphol 19(4):329-35, 2011. e-Pub 2011. PMID: 21386704.
51. Tsuta K, Kalhor N, Raso MG, Wistuba II, Moran CA. Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases. Hum Pathol 42(4):578-85, 2011. e-Pub 2011. PMID: 21329962.
52. Kalhor N, Suster S, Moran CA. Spindle Cell Thymomas (WHO Type A) With Prominent Papillary and Pseudopapillary Features: A Clinicopathologic and Immunohistochemical Study of 10 Cases. Am J Surg Pathol 35(3):372-7, 2011. PMID: 21317709.
53. Weissferdt A, Kalhor N, Suster S. Malignant mesothelioma with prominent adenomatoid features: a clinicopathologic and immunohistochemical study of 10 cases. Ann Diagn Pathol 15(1):25-9, 2011. e-Pub 2010. PMID: 21106421.
54. Tsuta K, Raso MG, Kalhor N, Liu DD, Wistuba II, Moran CA. Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung. Lung Cancer 71(1):34-41, 2011. e-Pub 2010. PMID: 20462655.
55. Tsuta K, Raso MG, Kalhor N, Liu DC, Wistuba II, Moran CA. Sox10-positive sustentacular cells in neuroendocrine carcinoma of the lung. Histopathology 58(2):276-85, 2011. PMID: 21323953.
56. Weissferdt A, Kalhor N, Suster S, Moran CA. Primary angiosarcomas of the anterior mediastinum: A clinicopathologic and immunohistochemical study of 9 cases. Hum Pathol 41(12):1711-7, 2010. e-Pub 2010. PMID: 20709359.
57. Moran CA, Kalhor N, Suster S. Invasive spindle cell thymomas (WHO Type A): a clinicopathologic correlation of 41 cases. Am J Clin Pathol 134(5):793-8, 2010. PMID: 20959663.
58. Weissferdt A, Kalhor N, Suster S, Moran CA. Adenomatoid spindle cell thymomas: a clinicopathological and immunohistochemical study of 20 cases. Am J Surg Pathol 34(10):1544-9, 2010. PMID: 20852406.
59. Kalhor N, Marom EM, Moran CA. Primary myxoma of the lung. Ann Diagn Pathol 14(3):178-81, 2010. e-Pub 2009. PMID: 20471563.
60. Kalhor N, Suster S, Moran CA. Primary sclerosing neuroendocrine carcinomas of the lung: A clinicopathologic and immunohistochemical study of 10 cases. Am J Clin Pathol 133(4):618-22, 2010. PMID: 20231615.
61. Kalhor N, Staerkel GA, Moran CA. So-called sclerosing hemangioma of lung: current concept. Ann Diagn Pathol 14(1):60-7, 2010. e-Pub 2009. PMID: 20123460.
62. Solis LM, Raso MG, Kalhor N, Behrens C, Wistuba II, Moran CA. Primary oncocytic adenocarcinomas of the lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases. Am J Clin Pathol 133(1):133-40, 2010. PMID: 20023269.
63. Kalhor N, Moran. Primary Mediastinal Neuroendocrine Tumors. Diagnostic Histopathology 16(5):237-242, 2010.
64. Gustafson S, Medeiros LJ, Kalhor N, Bueso-Ramos CE. Anaplastic large cell lymphoma: another entity in the differential diagnosis of small round blue cell tumors. Ann Diagn Pathol 13(6):413-27, 2009. PMID: 19917480.
65. Kalhor N, Ramirez PT, Deavers MT, Malpica A, Silva EG. Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol 33(4):633-8, 2009. PMID: 19145204.
66. Deavers MT, Kalhor N, Silva EG. Diagnostic problems with trophoblastic lesions. Arch Pathol Lab Med 132(2):168-74, 2008. PMID: 18251570.
67. Kalhor N, Zander DS, Liu J. TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material. Mod Pathol 19(8):1117-23, 2006. e-Pub 2006. PMID: 16680154.

Manuals, Teaching Aids, Other Teaching Publications

1. . Thoracic chapter, Pathology Grossing Manual, 2010-2012, 8888.
2. . Comprehensive Review of Thoracic Pathology. Video Conference. The Oakstone Institute, 2014.

Abstracts

1. Guerrouahen B, Kalhor N, Wistuba I, Parra E, Wang W, Mantha G, Reddy N, Famobio T, Walters K, Contreras A. Tissue-Based Multiplexing, Multispectral Immunofluorescence Testing in a CLIA-Like Laboratory Environment: A Step Forward Towards Clinical Testing. Mod Pathol 104(3):S1784-85, 2024.
2. Ye Q, Liu A, Estrella J, Kalhor N||, Albarracin C, Ding QQ, Wu Y,. TRPS1 Expression in Neuroendocrine Neoplasms of Breast and Other Organs. Mod Pathol 103(3):S237, 2023.
3. Rojas Alvarez F, Chen P, Serrano A, Fujimoto J, Hong L, Zhu B, Hu X, Salehjahromi M, Bandyopadhyay R, Aminu M, Kalhor N||, Wistuba I, Zhang J, Wu J, Solis Soto L. Artificial Intelligence-Assisted Tissue Morphology Analysis Reveals the Lymphocytes Infiltration Progression from Lung Preneoplasia to Invasive Adenocarcinoma. Mod Pathol 103(3):S1655-56, 2023.
4. Shien K, Ruder D, Ileana E, Papadimitrakopoulou V, Frampton G, Behrens C, Kalhor N, Lee JJ, Tang X, Herbst RS, Wistuba I, Izzo J. Detection of a novel ALK fusion variant in lung adenocarcinoma using a comprehensive genomic analysis. Cancer Research 76(14 Suppl), 2016.
5. Fujimoto J, Zhang J, Pickering CR, Kadara H, Liu CG, Drummond JA, Muzny DM, Doddapaneni H, Weissferdt A, Wheeler DA, Myers JN, Wang J, Wistuba II, Kalhor N, Moran CA. Identification of Novel Somatic Variants in Thymic Epithelial Tumors by Next-Generation Sequencing. 103rd Annual Meeting, The United States and Canadian Academy of Pathology (USCAP), San Diego, California, 2014.
6. Mann SE, Moran CA, Kalhor N. Localized Malignant Epitheloid Mesothelioma. 103rd Annual Meeting, The United States and Canadian Academy of Pathology (USCAP), San Diego, California, 2014.
7. Weissferdt A, Kalhor N, Liu H, Rodriguez, Fujimoto J, Tang X, Wistuba II, Moran CA. Primary Mediastinal Seminomas: A Comprehensive Immunohistochemical Study Using Novel Markers. 103rd Annual Meeting, The United States and Canadian Academy of Pathology (USCAP), San Diego, California, 2014.
8. Weissferdt A, Kalhor N, Liu H, Rodriguez J, Fujimoto J, Tang X, Wistuba II, Moran CA. Paraganglioma Versus Thymic Carcinoid Tumor: An Immunohistochemical Study of 46 Cases. 103rd Annual Meeting, The United States and Canadian Academy of Pathology (USCAP), San Diego, California, 2014.
9. Liu H, Mino B, Parra E, Fujimoto J, Tang X, Weissferdt, Kalhor N, Wistuba II, Moran CA. Effects of Slide Storage on PTEN Antigenicity: Implications for Clinical Trials and Translational Research. 103rd Annual Meeting, The United States and Canadian Academy of Pathology (USCAP), San Diego, California, 2014.
10. Mino B, Roy-Chowdhuri S, Gonzalez I, Kiriakova G, Liu H, Fujimoto J, Tang X, Weissferdt A, Kalhor N, Wistuba II, Moran CA, Rodriguez-Canales J. Optimization of a Cell Transfer Technique for Multiple Immunocytochemistry from Single Cytology Smears for Pathology and Translational Research. 103rd Annual Meeting, The United States and Canadian Academy of Pathology (USCAP), San Diego, California, 2014.
11. Maki U, Fujimoto J, Yoo SY, Gower A, Shen L, Garcia M, Kabbout M, Chow CW, Ki Hong W, Kalhor N, Wang J, Moran C, Spira A, Coombes KR, Wistuba II, Kadara H. Transcriptomic architecture of the airway field cancerization in early-stage non-small cell lung cancer. 104th Annual American Association for Cancer Research (AACR) Meeting 73(8 Suppl), 2013.
12. Kalhor N, Fujimoto J, Rodriguez J, Byers LA, Kies MS, Hofstetter WL, El-Naggar AK, Bell D. MECT1-MAML2 Fusion Transcript Expression in Lung Mucoepidermoid Carcinoma. 102nd Annual Meeting, United States & Canadian Academy of Pathology, 2013.
13. Weissferdt A, Kalhor N, Moran CA. Comparative Immunohistochemical Analysis of Pulmonary and Thymic Neuroendocrine Carcinomas Using Pax8 and TTF-1. 102nd Annual Meeting, United States & Canadian Academy of Pathology, 2013.
14. Tang X, Xue Y, Su X, Harun N, Cai Y, Behrens C, Papadimitrakopoulou V, Blowers D, Moran C, Kalhor N, Rice D, Beran G, Lee J, Kilgour E, Wistuba II. Fibroblast growth factor receptor 1 (FGFR1) gene copy number gain in adenocarcinoma and squamous cell carcinoma of the lung. ASCO 49th Annual Meeting, Chicago, IL, 2013.
15. William WN, Erickson H, Wei C, Hanson N, Tang X, Rodriguez J, Kalhor N, Lee J, Ki Hong W, Kim E, Wistuba II. Differences in mutation patterns of diagnostic versus post-chemotheraphy samples in patients with metastatic non-small cell lung cancer (NSCLC). ASCO 49th Annual Meeting, Chicago IL, 2013.
16. Papadimitrakopoulou V, Wistuba II, Lee J, Tsao AS, Kalhor N, Fossella F, Heymach J, Alden CM, Gettinger SN, Coombes KR, Saintigny P, Tang X, Duffield E, Boyer J, Davis SE, Powis G, Mauro DJ, Rubin EH, Ki Hong W, Herbst RS. BATTLE-2 program: A biomarker-integrated targeted therapy study in previously treated patients with advanced non-small cell lung cancer (NSCLC). ASCO 49th Annual Meeting. Chicago IL, 2013.
17. Kilari D, Tang X, Chow C, Fujimoto J, Kalhor N, Swisher S, Wistuba II, Stewart DJ, Siddik ZH, Kim ES. Copper transporter CTR1 expression and tissue platinum concentration in NSCLC. ASCO 49th Annual Meeting. Chicago IL, 2013.
18. Sepesi B, Correa AM, Pataer A, Kalhor N, Bekele NB Erasmus JJ, Heymach J, Hofstetter WL, Wistuba II, Swisher SG, the University of Texas MD Anderson Lung Cancer Moonshot Group. The Impact of Histopathologic Response on Pathologic TNM Lung Cancer Staging System (AJCC 7th) Following Neoadjuvant Chemotherapy. Society of Thoracic Surgeons 49th Annual Meeting, 2013.
19. Fujimoto J, Kadara H, Woo SK, Garcia M, Kabbout M, Basey A, Wang J, Coombes KR, Kim ES, Hong WK, Kalhor N, Moran C, Wistuba II. Gene expression profiling of lung field cancerization reveals potential targets for chemoprevention. The 101st Annual Meeting of the Japanese Society of Pathology, 2012.
20. Hong Wk, Kalhor N, Moran C, Wistuba II. Gene expression profiling of lung tumors and matched normal airways reveals common and disparate aberrant pathways in squamous cell carcinoma and adenocarcinoma development and potential targets for chemoprevention in early stage lung cancer patients. 103rd Annual American Association for Cancer Research (AACR) 72(8 Suppl), 2012.
21. Kalhor N, Tang X, Kim ES, Padadimitrakopulou V, Lee JJ, Herbst RS, Alden CM, Erickson HS, Moran CA, Tam AL, Gupta S, Lippman SM, Hong WK, Wistuba II. Feasibility of Molecular Testing in Patients with Chemorefractory Non-Small Cell Carcinoma, 2012.
22. Godoy M, Boonsirikamchai P, Marom E, Truong M, Naidich D, Kalhor N, Moran C. Adenocarcinoma: Radiologic-Pathologic Correlation. 98th Radiologic Society of North America (RSNA). e-Pub 2012.
23. Kim ES, Chow CW, Kalhor N, Fujimoto J, Swisher SG, Wistuba II, Stewart DJ, Siddik Z. Correlation between Tissue Platinum Concentration and Tumor Response in NSCLC. 14th World Conference on Lung Cancer, 2011.
24. Galindo HG, Suraokar M, Behrens C, Woods DM, Kalhor N, Aldape KD, Fujimoto J, Herbst RS, Erickson HS, Wistuba II. Identification of prostate stem cell antigen (PSCA) as a potential marker for lung cancer brain metastasis. 102nd Annual Meeting, Association for Cancer Research (AACR) 71(8), 2011.
25. Guo M , Si Q, Gong Y, Kalhor N, Chen S, Moran C. EGFR Mutations in Exons 18, 19 and 21 Are Closely Associated with TTF-1 Positive Lung Adenocarcinoma. 100th Annual Meeting, The United States and Canadian Academy of Pathology. Mod Pathol 24(Suppl 1):411A (#1749), 2011.
26. Nunez MI, Behrens C, Woods DM, Lin H, Suraokar M, Kadara H, Minna JD, Hofstetter W, Kalhor N, Hong WK, Lee JJ, Franklin W, Stewart D, Wistuba II. High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and EGFR Mutation. 100th Annual Meeting, The United States and Canadian Academy of Pathology. Mod Pathol 24(Suppl1):420A (#1788), 2011.
27. Zenali M, Deavers MT, Kalhor N, Prieto VG. Malignant Mesothelioma Expresses Melan-A (A-103), a Possible Diagnostic Pitfall. 100th Annual Meeting, The United States and Canadian Academy of Pathology. Mod Pathol 24(Suppl 1):429A (#1826), 2011.
28. Solis LM, Raso MG, Fujimoto J, Behrens C, Woods DM, Mendoza G, Kalhor N, Moran CA, Wistuba II. Molecular abnormalities associated to the progression of lung adenocarcinomas with BAC features from non-invasive to invasive patterns. 102nd Annual Meeting, American Association for Cancer Research (AACR), 2011.
29. Weissferdt A, Kalhor N, Suster S, Moran CA. Pleural malignant mesothelioma with prominent adenomatoid features: clinicopathological and immunohistochemical analysis of 10 cases. XXVIIIth International Congress of the International Academy of Pathology. Histopathology 57(Suppl 1):219 (#607), 2010.
30. Weissferdt A, Hernandez JC, Kalhor N, Moran CA. Pancytokeratin, cytokeratin 5/6, cytokeratin 7, cytokeratin 20, TTF-1 and p63 as a diagnostic tool separating non-small cell carcinomas in biopsy specimens. XXVIIIth International Congress of the International Academy of Pathology. Histopathology 57(Suppl 1):221 (#611), 2010.
31. Weissferdt A, Hernandez-Prera JC, Kalhor N, Moran CA. Spindle cell thymomas: an immunohistochemical study of 30 cases. XXVIIIth International Congress of the International Academy of Pathology. Histopathology 57(Suppl 1):240 (#667), 2010.
32. Zenali M , Soto LMS, Roso G, Wistuba II, Moran CA, Kalhor N. Mucinous Carcinoma (Colloid Carcinoma) of the Lung, an Immunohistochemical and Molecular Analysis. 99th Annual Meeting, The United States and Canadian Academy of Pathology. Mod Pathol 23(Suppl1):416A (#1860), 2010.

Book Chapters

1. Kalhor N, Moran CA. "Extrinsic Allergic Alveolitis" and Eosinophilic Pneumonia". In: Diagnostic Pathology, Non-neoplastic Pediatrics. AMIRSYS Publishing, 2013.
2. Kalhor N, Moran CA. “Pathology of Neuroendocrine Tumors”. In: Neuroendocrine Tumors (Current Clinical Oncology). Humana Press, 2011.
3. Kalhor N Moran CA. "Immunological and molecular studies in lung cancer”. In: Immunological & Molecular Diagnosis of Cancer. Nova Publishers, 2010.

Books (edited and written)

1. Moran CA, Suster S. Medical editor for book of “Diagnostic Pathology: Thoracic. In: Diagnostic Pathology: Thoracic. Amirsys Inc: Salt Lake City, Utah, 2011.